Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings.
OBJECTIVE
We have reviewed the endoscopic retrograde cholangiopancreatography (ERCP) images of patients with autoimmune pancreatitis (AIP) and pancreatic carcinoma (Pca) in an attempt to identify findings that would facilitate making a differential diagnosis between AIP and Pca.


METHODS
The study cohort consisted of 39 patients diagnosed with AIP and 62 patients diagnosed with Pca. The ERCP findings in the pancreatic duct and biliary tract were compared between the two groups.


RESULTS
The ERCP images revealed that AIP patients had a higher prevalence of narrowing of the main pancreatic duct (MPD) for ≥ 3 cm of its length and a higher prevalence for the presence of side branches in the narrowed portion of the MPD than Pca patients (p < 0.001 and p < 0.001, respectively). In contrast, the prevalence of an upstream MPD having a maximal diameter ≥ 4 cm was significantly higher in the Pca patient group (p < 0.001). The discriminant analysis identified three significant factors: (1) whether or not side branches were present; (2) total length of the narrowed portion of the MPD; (3) maximal diameter of the upstream MPD. It was impossible to differentiate Pca from AIP in the two Pca patients in whom ERCP revealed both narrowing of the MPD for > 5 cm of its length and the presence of side branches.


CONCLUSIONS
Among our patient cohort, the ERCP findings in terms of the length of the narrowed portion of the MPD, the presence of side branches, and maximal diameter of the upstream MPD enabled differential diagnosis between AIP and Pca in most of the cases. However, it must be borne in mind that some Pca patients have ERCP findings similar to those of AIP patients.
Nishino
Takayoshi
T
Department of Gastroenterology, Yachiyo Medical Center, Tokyo Women's Medical University, 477-96 Owada-Shinden, Yachiyo, Chiba 276-8542, Japan. takanishino@mm.em-net.ne.jp
Oyama
Hiroyasu
H
Toki
Fumitake
F
Shiratori
Keiko
K
D000368:Aged; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000473:pathology*; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000379:methods*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010183:Pancreatic Ducts / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000473:pathology*; D010195:Pancreatitis / Q000175:diagnosis / Q000276:immunology / Q000473:pathology*; D015995:Prevalence; D012189:Retrospective Studies
J Gastroenterol. 2007 Jul;42(7):550-9
17653651
Dig Dis Sci. 1995 Jul;40(7):1561-8
7628283
Am J Gastroenterol. 2007 Aug;102(8):1646-53
17555461
Pancreas. 2008 Oct;37(3):e62-7
18815540
J Gastroenterol. 2006 Jul;41(7):626-31
16932998
J Gastroenterol. 2006 Jul;41(7):613-25
16932997
Gastrointest Endosc. 2004 Dec;60(6):937-44
15605009
Gastroenterology. 2000 Mar;118(3):573-81
10702209
Gastrointest Endosc. 2002 Apr;55(4):494-9
11923760
Pancreas. 2005 Jan;30(1):76-82
15632703
Am J Gastroenterol. 2003 Dec;98(12):2679-87
14687817
J Gastroenterol. 2009;44(2):154-9
19214678
N Engl J Med. 2001 Mar 8;344(10):732-8
11236777
Intern Med. 2006;45(8):497-501
16702740
Am J Gastroenterol. 2003 Dec;98(12):2694-9
14687819
Gut. 2007 Dec;56(12):1719-24
17525092
World J Gastroenterol. 2006 Apr 28;12(16):2487-96
16688792
Gut. 2003 May;52(5):683-7
12692053
Hum Pathol. 1991 Apr;22(4):387-95
2050373
Gastrointest Endosc. 2007 Jan;65(1):99-108
17185087
Clin Gastroenterol Hepatol. 2006 Aug;4(8):1010-6; quiz 934
16843735